Prestige Consumer Healthcare PBH International OTC Healthcare — Advertising and marketing
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept us-gaap:MarketingAndAdvertisingExpense.
The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prestige Consumer Healthcare's international otc healthcare — advertising and marketing.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Prestige Consumer Healthcare's international OTC healthcare — advertising and marketing?
- Prestige Consumer Healthcare (PBH) reported international OTC healthcare — advertising and marketing of $7.92M in Q1 2026.
- How has Prestige Consumer Healthcare's international OTC healthcare — advertising and marketing changed year-over-year?
- Prestige Consumer Healthcare's international OTC healthcare — advertising and marketing increased by 9.8% year-over-year, from $7.21M to $7.92M.
- What is the long-term trend for Prestige Consumer Healthcare's international OTC healthcare — advertising and marketing?
- Over 4 years (2022 to 2026), Prestige Consumer Healthcare's international OTC healthcare — advertising and marketing has grown at a 10.7% compound annual growth rate (CAGR), from $18.63M to $27.94M.
- What does international OTC healthcare — advertising and marketing mean?
- This reflects the total expenditure dedicated to promoting and advertising over-the-counter healthcare brands within the international market. These investments are critical for maintaining brand awareness, driving consumer demand, and defending market share against competitors. It is a key lever for top-line growth in consumer-facing healthcare businesses.